Research Now :: Nationwide Children's Hospital

Contact Research Now

IN THIS ISSUE ::

Changes to the NAV Web Portal Reports

Noon Seminar with Research Retreat Keynote Speaker, Walter Orenstein, MD, on September 16

Hazardous Material Transportation Requirements Reminder

Scott Loiler, PhD, Principal Investigator for Center for Gene Therapy

Vijay Nadella Appointed Technical Director of the Biomedical Genomics Core

Funding Available Through New Nationwide/OSU College of Medicine Cross-Campus-Collaborative Pilot Program, Next Deadline December 31

Research Live with David Greenberg, PhD, on September 24

Register for the 2014 Research Retreat by Friday, September 5

Vaccination May be Necessary to Prevent Reinfection After Initial Cure of Hepatitis C
Christopher Walker, PhD, a principal investigator in the Center for Vaccines and Immunity, led a study on how an initial cure of chronic hepatitis C infection does not reduce the risk or severity of reinfection with hepatitis C.

Discovery of New Form of Dystrophin Protein Could Lead to Therapy for Some Duchenne Muscular Dystrophy Patients
A team led by Kevin Flanigan, MD, principal investigator in the Center for Gene Therapy, have discovered a new form of dystrophin, a protein critical to normal muscle function, and identified the genetic mechanism responsible for its production.

Zinc Supplementation Improves Growth in NICU Babies with Chronic Lung Disease
In a recent study, NCH gastroenterologist Ala Shaikhkhalil, MD, demonstrated that zinc supplementation is promising for improving growth in extremely low birthweight infants with chronic lung disease.

Recent Peer-Reviewed Publications from NCH Faculty (July-September Publications from PubMed)

Katherine Bline, MD, and Michael Thompson, MD, Receive AAP Resident Research Awards

Revised Visitor/Vendor Policy for The Research Institute at Nationwide Children’s Hospital

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000